Self-Renewal and Differentiation: Molecular Events that Commit ES Cells to Exit t
Self-Renewal and Differentiation: Molecular Events that Commit ES Cells to Exit t
批准号:
8381275
负责人:
James Alexander Thomson
金额:
$36.96万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2014-07-31
关键词:
ActivinsAttentionBMP4Binding SitesBrachyury proteinCell Differentiation processCellsChorionic GonadotropinCommitDNA BindingDevelopmentEndodermEventExcisionFibroblast Growth FactorFibroblast Growth Factor 2Gene ExpressionGenesGenetic TranscriptionGenomeGenomicsMapsMeasuresMediatingMediator of activation proteinMesodermMolecularOutcomePhosphorylationPlacentaPopulationProteinsRNA InterferenceSignal TransductionTimechromatin immunoprecipitationclinically relevantembryonic stem cellhuman embryonic stem celloverexpressionpluripotencypoly(L-glutamic acid(60)-L-alanine(30)-L-tyrosine(10))promoterresponseself-renewaltranscription factortrophoblast
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project 2: Self-Renewal and Differentiation: Molecular events that commit ES cells to exit the
pluripotent state. (James Thomson, PI)
A. SPECIFIC AIMS
In low (4 ng/ml) or absent exogenous bFGF, BMP4 induces human ES cells to form a homogenous population
of trophoblast, the outer layer of the placenta. However, we have recently found that in the presence of high
(100 ng/ml) concentrations of bFGF, BMP4 instead induces human ES cells to form a population of cells that
no longer express trophoblast markers, but instead transiently express brachyury, a mesoderm or
mesendoderm marker, and subsequently express a mixture of endoderm and mesoderm markers. In this
project, we will study how BMPs induce human ES cells to exit the pluripotent state and commit to
differentiation, and study how FGF mediates these divergent developmental outcomes in response to the same
inducer. Understanding how ES cells exit the pluripotent state and why this exit is generally irreversible is
central to achieving efficient reprogramming (Project 3), and understanding these key early lineage decisions
will allow more efficient differentiation to specific clinically-relevant lineages.
We will accomplish the following aims:
Aim 1. We will establish a detailed time course of gene expression in human ES cells upon BMP4-
induced differentiation, both in the presence (brachyury positive result) and absence (chorionic
gonadotropin positive result) of bFGF, and correlate these changes with the commitment to exit the
pluripotent state. Commitment will be measured by adding BMP4 for successively longer time periods,
removing BMP4, and then examining how many cells retain markers of pluripotency several days later. The
hypothesis of this aim is that the quantitative commitment curve will be most closely correlated with the
expression levels of the genes that directly control these differentiation events. We will subsequently overexpress
the transcription factors most closely associated with commitment, and we will downregulate genes by
RNA interference that are downregulated during commitment to identify those which are sufficient to mediate
differentiation to a brachyury-positive population. Preliminary results demonstrate that GATA2 and GATA3 are
both individually sufficient to mediate trophoblast differentiation in the absence of bFGF, so we are optimistic
that a single transcription factor will be sufficient to mediate human ES cell differentiation to a brachyury
positive population in the presence of bFGF.
Aim 2. We will use whole genome chromatin immunoprecipitation on chip (ChlP-chip) to map the
genomic binding sites of TGFp/Activin-activated Smad 2/3 and BMP-activated Smad 1/5/8 during BMP4-
induced differentiation. The central hypothesis of this aim is that Smad 2/3 directly activates the expression
of key pluripotency factors in human ES cells, directly suppresses the expression of genes that would
otherwise promote differentiation, and competes at the same promoters with Smad 1/5/8 which has the
opposing effects. A second hypothesis is that bFGF will change the DNA binding sites of Smad 1/5/8 during
BMP-induced differentiation, leading to the different developmental outcomes observed.
Aim 3. We will use whole genome chromatin immunoprecipitation on chip (ChlP-chip) to map genomic
binding sites of GATA2 and GATA3 during BMP4-induced differentiation. The hypothesis of this aim is
that GATA2 and GAT A3 directly negatively regulate the transcription of key pluripotency genes, and directly
positively regulate their own transcription, so that once they are induced by Smads, GAT A expression
becomes self-sustaining and BMP-independent, and thus differentiation continues even upon BMP removal. A
second hypothesis is that bFGF will change the DNA binding sites of GATA2/GATA3 during BMP-induced
differentiation, leading to the different developmental outcomes observed.
Aim 4. We will identify proteins that are differentially phosphorylated between BMP4-induced
trophoblast differentiation (no bFGF) and BMP-induced brachyury positive cellular differentiation (high
bFGF) to identify mediators of FGF signaling that cause the switch between these divergent
developmental outcomes. The hypothesis of this aim is that differential phosphorylation of a limited number
of transcription factors is casually related to the different developmental outcomes observed after BMP
induction in the presence or absence of bFGF. Differentiation commitment curves will again become key for
focusing attention to relevant phosphorylation events.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transplantation of MHC Homozygous Vascular Progenitors in Primates
-
批准号:9355220
-
项目类别:
-
资助金额:$88.77万
-
财政年份:2016
-
负责人:James Alexander Thomson
-
依托单位:
Transplantation of MHC Homozygous Vascular Progenitors in Primates
-
批准号:9215301
-
项目类别:
-
资助金额:$90.36万
-
财政年份:2016
-
负责人:James Alexander Thomson
-
依托单位:
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
-
批准号:8668606
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2012
-
负责人:James Alexander Thomson
-
依托单位:
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
-
批准号:8414419
-
项目类别:
-
资助金额:$112.5万
-
财政年份:2012
-
负责人:James Alexander Thomson
-
依托单位:
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
-
批准号:8768889
-
项目类别:
-
资助金额:$202.02万
-
财政年份:2012
-
负责人:James Alexander Thomson
-
依托单位:
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
-
批准号:8516134
-
项目类别:
-
资助金额:$109.43万
-
财政年份:2012
-
负责人:James Alexander Thomson
-
依托单位:
MIDWEST PROGENITOR CELL CONSORTIUM
-
批准号:8358235
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2011
-
负责人:James Alexander Thomson
-
依托单位:
MIDWEST PROGENITOR CELL CONSORTIUM
-
批准号:8173156
-
项目类别:
-
资助金额:$4.13万
-
财政年份:2010
-
负责人:James Alexander Thomson
-
依托单位:
DETERMINANTS OF SELF-RENEWAL, DIFFERENTIATION, AND REPROGRAMMING OF HESCS
-
批准号:8173148
-
项目类别:
-
资助金额:$4.13万
-
财政年份:2010
-
负责人:James Alexander Thomson
-
依托单位:
WNPRC STEM CELL RESOURCE
-
批准号:8173102
-
项目类别:
-
资助金额:$10.33万
-
财政年份:2010
-
负责人:James Alexander Thomson
-
依托单位:
Midwest Progenitor Cell Consortium
-
批准号:8323131
-
项目类别:
-
资助金额:$113.87万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
Midwest Progenitor Cell Consortium
-
批准号:8661226
-
项目类别:
-
资助金额:$114.23万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
Midwest Progenitor Cell Consortium
-
批准号:8462666
-
项目类别:
-
资助金额:$105.88万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
Midwest Progenitor Cell Consortium
-
批准号:8722409
-
项目类别:
-
资助金额:$5.27万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
Midwest Progenitor Cell Consortium
-
批准号:7939693
-
项目类别:
-
资助金额:$107.45万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
Determinants of Self-Renewal, Differentiation, and Reprogramming of hESCs
-
批准号:7932409
-
项目类别:
-
资助金额:$43.55万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
Midwest Progenitor Cell Consortium
-
批准号:8114054
-
项目类别:
-
资助金额:$108.41万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
Midwest Progenitor Cell Consortium
-
批准号:7820075
-
项目类别:
-
资助金额:$110.13万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
IMPROVED LENTIVIRAL VECTORS FOR PRIMATE EMBRYONIC STEM CELLS
-
批准号:7958737
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
WNPRC STEM CELL RESOURCE
-
批准号:7958782
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2009
-
负责人:James Alexander Thomson
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: